Some people may regain weight over time, especially if treatment is stopped suddenly or without lifestyle support
Key Market Highlights The global GLP-1 analogues market was valued at US$ 51.6 Billion in 2024 The market is expected to reach US$ 211.8 Billion by 2035 The industry is forecast to expand at a CAGR of 13.7% during 2025-2035 North America accounted for the largest market share of 68.4% in 2024 The Subcutaneous route of administration segment held 78.2% market share in 2024 Major industry participants include Novo Nordisk A/S, Eli Lilly and Company, Sanofi, and AstraZeneca Rising Type 2 Diabetes Cases Accelerating Market Growth The growing prevalence of type 2 diabetes remains one of the most significant growth drivers for the GLP-1 analogues market
doi: 10.1073/pnas.212319799 160 FischerJLMihelcEMPollokKESmithML
By activating the glucagon receptor, it promotes the breakdown of fat for energy, potentially leading to even more significant weight loss
There are three ways to access retatrutide: (1) enroll in a clinical trial (free, pharmaceutical-grade, search ClinicalTrials.gov), (2) get a prescription for compounded retatrutide from a telehealth provider or compounding pharmacy ($200-500/month), or (3) purchase research peptides from grey-market vendors ($150-500/month, no prescription, quality varies)
Then falls out
